OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Raptiva

efalizumab

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Raptiva
Proper name
efalizumab
Licence type
351(a)
BLA number
125075
Applicant
Genentech, Inc.
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
125MG Injection Subcutaneous Single-Dose Vial Disc October 27, 2003

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity